Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NASDAQ:LGVN
Recent news which mentions NASDAQ:LGVN
LGVN Stock Earnings: Longeveron Misses EPS, Beats Revenue for Q2 2024
August 14, 2024
Tickers
LGVN
Tags
NASDAQ:LGVN
Market News
Earnings Reports
From
InvestorPlace
Longeveron (LGVN) Stock Pops on Phase 2 Trial Updates
July 29, 2024
Tickers
LGVN
Tags
Today's Market
NASDAQ:LGVN
Market News
From
InvestorPlace
Why Is Longeveron (LGVN) Stock Up 120% Today?
June 12, 2024
Tickers
LGVN
Tags
Today's Market
NASDAQ:LGVN
Market News
From
InvestorPlace
LGVN Stock Earnings: Longeveron Beats EPS, Beats Revenue for Q1 2024
May 14, 2024
Tickers
LGVN
Tags
Market News
Earnings Reports
LGVN
From
InvestorPlace
Why Is Longeveron (LGVN) Stock Up 82% Today?
April 08, 2024
Tickers
LGVN
Tags
Today's Market
NASDAQ:LGVN
LGVN
From
InvestorPlace
Longeveron (NASDAQ: LGVN) Reports 100% 5-Year Survival In Trial For Rare Pediatric Disease HLHS (Compared To 80% Survival In Historical Trials) To Market
September 12, 2023
Tickers
AMGN
LGVN
MRNA
Tags
NASDAQ:LGVN
From
News Direct
Upcoming Phase 2 Data Expected For Longeveron’s (NASDAQ: LGVN) Drug For the $4+ Billion Alzheimer’s Sector – What To Look For
September 07, 2023
Tickers
ABOS
BIIB
LGVN
TLSA
Tags
NASDAQ:LGVN
From
News Direct
Longeveron Announces Key Additions To Its Leadership Team and Board As It Gears Up For Phase 2 Trials For Its Lead Drug Candidate For Several Conditions
August 08, 2023
Tickers
AMGN
LGVN
LLY
Tags
NASDAQ:LGVN
From
News Direct
HLHS Is A Rare And Serious Congenital Heart Disease With A 33% Neonatal Death Rate — Could Longeveron’s Lomecel-B Improve Outcomes?
July 07, 2023
Tickers
LGVN
Tags
NASDAQ:LGVN
From
News Direct
LGVN Stock Earnings: Longeveron Misses EPS, Revenue Estimates
May 12, 2023
Tickers
LGVN
Tags
Market News
LGVN
Top Stocks Portfolio
From
InvestorPlace
Why Is Longeveron (LGVN) Stock Up Today?
March 10, 2022
Tickers
LGVN
Tags
Market News
LGVN
Today's Market
From
InvestorPlace
Why Longeveron’s Good News Isn’t Telling Us the Whole Truth
December 10, 2021
Tickers
LGVN
Tags
NASDAQ:LGVN
Hot Stocks
Market News
From
InvestorPlace
Even After a Blistering Rally, Longeveron Is Still Buyable
November 30, 2021
Tickers
LGVN
Tags
Stocks to Buy
NASDAQ:LGVN
LGVN
From
InvestorPlace
LGVN Stock: 7 Things to Know as Longeveron Rockets 100% Higher
November 24, 2021
Tickers
LGVN
Tags
Today's Market
NASDAQ:LGVN
LGVN
From
InvestorPlace
LGVN Stock Alert: The Huge FDA News Sending Longeveron to the Moon Today
November 18, 2021
Tickers
LGVN
Tags
LGVN
Market News
Today's Market
From
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.